WEKO3
アイテム
Pancreas Cancer
https://repo.qst.go.jp/records/61940
https://repo.qst.go.jp/records/6194088e7f8b7-7b42-43d9-8944-dbb2ef1a8ccb
| Item type | 会議発表用資料 / Presentation(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2006-12-05 | |||||
| タイトル | ||||||
| タイトル | Pancreas Cancer | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
| 資源タイプ | conference object | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Yamada, Shigeru
× Yamada, Shigeru× Katou, Hirotoshi× Hara, Ryusuke× Yasuda, Shigeo× Kamada, Tadashi× Tsujii, Hirohiko× Tsuji, Hiroshi× Yanagi, Takeshi× Mizoe, Junetsu× Miyamoto, Tadaaki× Yoshikawa, Kyosan× Kishimoto, Riwa× Kandatsu, Susumu× Saisho, Hiromitsu× 山田 滋× 加藤 博敏× 原 竜介× 安田 茂雄× 鎌田 正× 辻井 博彦× 辻 比呂志× 柳 剛× 溝江 純悦× 宮本 忠昭× 吉川 京燦× 岸本 理和× 神立 進× 税所 宏光 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Adenocarcinoma of the pancreas continues to be a significant source of cancer mortality in Japan, resulting in approximately 19,000 deaths a year. It is the fifth leading cause of cancer-related deaths in Japan, with a less than 5% 5-year expected survival rate [1]. About 70-75% of patients with pancreas cancer present with locally advanced disease or distant metastases and have a median survival time of only 6 months. For unresectable pancreas cancer, the median survival time with extermal beam radiation (EBRT) was better than with surgical bypass [2] or stents alone [3]. The median survival OF EBRT alone was 4 to 7 months [4]. The median survival with combined EBRT and chemotherapy for locally unresectable tumor are 8 to 10 months [5] and better than with the EBRT alone. Local failure of these combined therapies was still 26 to 48 %. On the other hand, surgery with curative intent is undertaken in 15-20% of patients. Even after resection, the predicted 5-year survival rates are still less than 20% [1]. Local recurrences in the pancreatic bed are seen in 50% of the patients undergoing presumed curative resection [6]. We examined the effect of carbon ion therapy in terms of reducing the rate of local recurrence in patients with locally advanced adenocarcinoma of the pancreas or undergoing resection for adenocarcinoma of the pancreas. | |||||
| 会議概要（会議名, 開催地, 会期, 主催者等） | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | NIRS-CNAO Joint Symposium on Carbon Ion Radiotherapy | |||||
| 発表年月日 | ||||||
| 日付 | 2006-11-28 | |||||
| 日付タイプ | Issued | |||||
